In this context, altered irisin regulation links adverse cardiac remodeling and skeletal muscle dysfunction with metabolic comorbidities such as diabetes mellitus, obesity and metabolic syndrome [50,51]. This evidence concerns the gene FNDC5 and obesity disorder.